In the report, the analysts say that the target price is based on 9.5 times FY2024 P/E with a 0.5 standard deviation (s.d.) above its six-year average, given its sole supplier status with its major customer, Nestek Korea which it acquired a 53.3% stake in on Aug 12, 2022.

This comes after AEM’s presentation at the second CGS-CIMB Tech/EV conference on March 29, where the company announced its Test 2.0 solutions, which lowers cost of testing and provides a more complete test coverage for the new generation of semiconductor chips.

According to the report, AEM believes that its ability to customise solutions to the needs of their customers through Test 2.0 is their key competitive differentiating factor.

“The company believes its new customers could account for 10%-20% of FY2023 revenue, with further growth expected in FY2024 and beyond,” say the analysts.

They analysts add that AEM has seen stronger-than-expected orders from its major customer and earlier-than-expected success in securing orders from other potential customers.

See also: <a class='gtm_see_also_1_inread' style='text-decoration: underline;' href='https://www.theedgesingapore.com/capital/brokers-calls/cgs-cimb-sees-aems-possible-recovery-2hfy2023-and-potential-earnings-recovery?utm_source=website&utm_medium=article&utm_campaign=ONPAGESEO'>CGS-CIMB sees AEM's 'possible recovery' from 2HFY2023 and potential earnings recovery for FY2024</a>

Separately, updates from its key customers reveal a positive outlook on trade flows for AEM.

Intel updated that its fourth-generation Xeon processor for data centres, was being shipped to over 50 original equipment manufacturers (OEM) after receiving 450 design wins following a one-year delay.

Intel’s fifth generation processors are also scheduled to ship in 4Q2023 and 2024 respectively.

See also: <a class='gtm_see_also_2_inread' style='text-decoration: underline;' href='/capital/brokers-calls/rhb-upbeat-raffles-medicals-contract-win-providing-medical-services?utm_source=website&utm_medium=article&utm_campaign=ONPAGESEO'>RHB ‘upbeat’ on Raffles Medical’s contract win for providing medical services at Connect@Changi</a>

Intel also projected that the data centre processors market (by revenue) could see a low-20% CAGR over FY2022 to FY2027, from over US$40 billion ($53.4 billion) to exceed US$10 billion in FY2027.

However, the analysts view delivery delays and the loss of the sole supplier status for its major customer as downside risks that could negatively affect AEM’s profitability.

As at 1.26pm, shares in AEM are trading 24 cents higher or 1.89% up at $3.24.

CGS-CIMB keeps 'add' call on AEM with unchanged TP on expected net profit recovery

VTAC proposes business combination with live streaming platform 17LIVE

Data is the new oil but is it as dirty?

'Transition credits' could sweeten deal for early retirement of coal-fired power plants: MAS, McKinsey paper

DPM Lawrence Wong appointed as GIC’s deputy chairman

Will the Rising Sun keep rising?

Trade Stocks, ETFs, Forex and Futures with Phillip Nova:

CGS-CIMB keeps 'add' call on AEM with unchanged TP on expected net profit recovery

Related News

Highlights

VTAC proposes business combination with live streaming platform 17LIVE

Related News

CGS-CIMB lowers Sasseur REIT’s TP to 95 cents

AEM's lower FY2023 revenue guidance prompts target price changes

AEM 1HFY2023 earnings drop 76.2% y-o-y, lowers FY2023 revenue guidance